Jason N. Butler Analyst PerformanceManaging Director, Biotechnology Equity Research at Citizens JmpJason N. Butler is a stock analyst at Citizens Jmp focused in the medical sector, covering 19 publicly traded companies. Over the past year, Jason N. Butler has issued 27 stock ratings, including and buy recommendations. While full access to Jason N. Butler's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jason N. Butler's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings27 Last 0 YearsBuy Recommendations100.00% 27 Buy RatingsCompanies Covered19 Unique Companies Ratings Distribution27RatingsDistribution of strong buy, buy, hold, and sell ratings by Jason N. Butler.RatingPercentageCount Strong Buy0.0%0 ratings Buy100.0%27 ratings Hold0.0%0 ratings Sell0.0%0 ratingsthe majority (100.0%) have been Buy recommendations.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ94.7% of companies on NASDAQ18 companiesNYSEAMERICAN5.3% of companies on NYSEAMERICAN1 companyJason N. Butler, an analyst at Citizens Jmp, currently covers 19 companies listed on NASDAQ and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical17 companies89.5%Miscellaneous1 company5.3%Finance1 company5.3%Jason N. Butler of Citizens Jmp specializes in stock coverage within the Medical sector, with additional focus on and Finance companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE11 companies57.9%MED - DRUGS6 companies31.6%Miscellaneous1 company5.3%FIN - MISC SVCS1 company5.3% Jason N. Butler's Ratings History at Citizens Jmp Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsABVXAbivax5/26/2026Reiterated Rating$121.99$131.00Market Outperform$0.0000.00% ROIGHRSGH Research5/15/2026Lower Price Target$22.21$39.00Market Outperform$0.0000.00% ROIPGENPrecigen5/14/2026Boost Price Target$4.65$11.00Market Outperform$0.0000.00% ROIAVTXAvalo Therapeutics5/14/2026Lower Price Target$19.59$55.00Market Outperform$0.0000.00% ROIPRTAProthena5/8/2026Boost Price Target$10.85$20.00Market Outperform$0.0000.00% ROIAVTXAvalo Therapeutics5/6/2026Boost Price Target$21.87$62.00Market Outperform$0.0000.00% ROICRMDCorMedix4/28/2026Reiterated Rating$7.64$19.00Market Outperform$0.0000.00% ROINERVMinerva Neurosciences4/15/2026Initiated Coverage$5.87$14.00Market Outperform$0.0000.00% ROIPGENPrecigen3/26/2026Boost Price Target$4.04$9.00Market Outperform$0.0000.00% ROINSRXNasus Pharma3/26/2026Lower Price Target$2.66$18.00Market Outperform$0.0000.00% ROIThis stock has 30 days of quiet left (Ad)A small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When the SpaceX and xAI S-1 filing hits the SEC in June, analysts will comb through supplier disclosures and this company's name is expected to surface. Dylan Jovine has identified the ticker and laid out the full investment thesis. The stock is still quiet - but that window may be closing fast.See the overlooked supplier before the SpaceX S-1 changes everythingESPREsperion Therapeutics3/13/2026Boost Price Target$2.47$5.00Market Outperform$0.0000.00% ROIGHRSGH Research3/6/2026Boost Price Target$15.17$42.00Market Outperform$0.0000.00% ROIARGXargenex2/27/2026Boost Price Target$771.53$944.00Market Outperform$0.0000.00% ROIIRWDIronwood Pharmaceuticals2/26/2026Boost Price Target$3.67$10.00Market Outperform$0.0000.00% ROIACADACADIA Pharmaceuticals2/26/2026Boost Price Target$23.80$35.00Market Outperform$0.0000.00% ROIACADACADIA Pharmaceuticals2/3/2026Reiterated Rating$26.13$34.00Market Outperform$0.0000.00% ROIACHVAchieve Life Sciences11/25/2025Initiated Coverage$3.97$19.00Market Outperform$0.0000.00% ROIRAPPRapport Therapeutics11/7/2025Boost Price Target$25.12$80.00Market Outperform$0.0000.00% ROIWULFTeraWulf10/29/2025Boost Price Target$15.55$22.00Market Outperform$0.0000.00% ROIRZLTRezolute10/29/2025Boost Price Target$9.54$17.00Market Outperform$0.0000.00% ROIABVXAbivax9/25/2025Boost Price Target$82.55$114.00Market Outperform$0.0000.00% ROICRMDCorMedix9/9/2025Reiterated Rating$12.75$22.00Market Outperform$0.0000.00% ROICYTKCytokinetics9/2/2025Reiterated Rating$47.43$78.00Market Outperform$0.0000.00% ROIPGENPrecigen8/19/2025Boost Price Target$2.95$8.00Market Outperform$0.0000.00% ROIZVRAZevra Therapeutics8/13/2025Lower Price Target$9.25$18.00Market Outperform$0.0000.00% ROIACADACADIA Pharmaceuticals8/7/2025Boost Price Target$23.80$38.00Market Outperform$0.0000.00% ROIHALOHalozyme Therapeutics8/6/2025Boost Price Target$64.95$91.00Market Outperform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaThe Goldman Sachs GroupBerenberg BankJefferies Financial GroupCLSAWeiss RatingsUBS GroupJPMorgan Chase & Co.TD CowenTruist Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
